On August 4, 2023 Oragenics, Inc. announced it has entered into definitive agreements with two healthcare-focused investors, in which the Company issued in a private placement 404,728 shares of the Company?s common stock, 404,728 shares of Series E Mirroring Preferred Stock.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | -1.94% | -4.72% | -82.05% |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Mar. 29 | Oragenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-82.05% | 4.62M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- OGEN Stock
- News Oragenics, Inc.
- Oragenics, Inc. announced a financing transaction